For a firmer you, ask for Sculptra®

Sculptra® activates the skins ability to produce collagen1. It renews skin thickness and firmness, correcting shallow to deep wrinkles and folds2.  Sculptra® works gradually to build the foundations of a youthful, firmer you, day after day3.

Why renew?
Why use Sculptra, a collagen injectable from Galderma aesthetics

Why Sculptra®?

Sculptra® activates the skin’s ability to produce collagen, restoring the skin’s structure and firmness4. Collagen is a fibrous protein in the deeper layers of your skin and it plays a crucial role in keeping your skin looking young and healthy. As you age, your body’s collagen production decreases which in time leads to loose and saggy skin and the formation of facial wrinkles and folds5.
 
Sculptra®, the original collagen stimulator, helps renew your skin gradually with long-lasting results6. Sculptra® can provide more radiant-looking skin over time, giving you natural-looking results.

Treatment areas

Treatment areas

The Sculptra® collagen skin renewal treatment rejuvenates sagging skin by increasing volume and firmness7. Sculptra® helps gradually diminish smile lines (nasolabial folds), laugh lines (or marionette lines) and wrinkles to help give you firm and radiant-looking skin. Results may last for up to two years8. Sculptra® can help you achieve the look you desire.  

According to a clinical study9, 80% of users were still satisfied with their Sculptra® collagen stimulators treatment up to 25 months after their last injection.

Treatments with The Galderma aesthetics range - Sculptra, a collagen injectable
CHEEKS, MID FACE, LOWER FACE
Your treatment
light
Sculptra, a collagen injectable - treatments for you

Your Sculptra® treatment

Sculptra® is injected in the deep layers of your skin to stimulate its own collagen production10. You will gradually notice visible improvements of skin firmness and fullness, with results that can last up to two years11. On average, three Sculptra® treatment sessions are needed over a few months. Your doctor will work with you to determine the number of treatments needed to help achieve the look you want.

 

Sculptra® works subtly, improving facial areas gradually to help give you youthful and natural-looking results. 

How it works
light
Sculptra - the science behind

How it works

The active ingredient in Sculptra® is poly-L-Lactic acid, PLLA. PLLA is a biodegradable substance that has been used for decades in dissolvable stitches for wound management. When PLLA is injected into the deeper layers of your skin, it helps stimulate your skin’s own collagen production12. Sculptra® can help rejuvenate skin volume that has been lost due to aging13.

80%

of patients rated Sculptra® as good to excellent after up to 25 months14

100%

of patients would recommend Sculptra® to a friend15

Proven aesthetic results since

200616

Before & After

Hillary_Durham_BEFORE
Sanne_Friis_BEFORE
Hillary_Durham_BEFORE
Sanne_Friis_BEFORE
Before Hillary_Durham_BEFORE
After Hillary_Durham_AFTER
Caption
  • Multiple treatments and/or products may have been used
  • Individual results may vary
  • Consult your doctor to determine what treatment is best for you
Before Sanne_Friis_BEFORE
After Sanne_Friis_AFTER
Caption
  • Multiple treatments and/or products may have been used
  • Individual results may vary
  • Consult your doctor to determine what treatment is best for you

Frequently asked questions

Sculptra® is distributed by Galderma. Galderma is a pharmaceutical company with over 6,000 employees worldwide. The company specializes in dermatology and is present in more than 100 countries. To read more about Galderma visit About Galderma

Are you looking for a clinic?

Our portfolio of products

Galderma has developed a diverse portfolio of products that work together.

The Galderma aesthetics range, Restylane Lyft and Deyfne

Refine

Refine your facial features by lifting and shaping contours, filling lines and wrinkles or creating natural-looking volume.

The Galderma aesthetics range, Restylane Skinboosters

Refresh

Refresh your skin from within with a boost of hyaluronic acid, for a refreshed and vibrant long-lasting look.

References

  1. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  2. Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
  3. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Bohnert K et al. Plast Reconstr Surg 2019;127(4):1684–92
  4. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  5. Fisher GJ et al. Arch Dermatol 2008;144(5):666–72.; Werschler WP et al. J Clin Aesthet Dermatol 2015;8(10 Suppl):S2–S7.
  6. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  7. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  8. Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8. 
  9. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
  10. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  11. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
  12. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  13. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.; Chen HH et al. JAMA Facial Plast Surg 2015;17(1):39–43.
  14. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
  15. Mest DR and Humble G. Dermatol Surg 2006;32(11):1336–45.
  16. Sculptra was developed and CE approved for aesthetic use in the European market in 1999.